Printer Friendly

Hormonal contraception and HIV: consensus statement.

The World Health Organization Headquarters Office and Regional Office for Africa, in partnership with the Reproductive Health and HIV Research Unit of the University of Witwatersrand in South Africa, International Planned Parenthood Federation Africa Region and Family Health International (FHI), convened a meeting of 72 representatives from 17 francophone, lusophone and anglophone sub-Saharan African countries on hormonal contraception and HIV: science and policy. The meeting reviewed data and information on the association between use of hormonal contraception and the risk of acquiring HIV infection.

A study published in 2004 on a cohort of sex workers followed over many years in Mombasa, Kenya, showed that users of hormonal contraception have a 1.5-fold (combined oral contraceptives [COCs]) to 1.8-fold (depot-medroxyprogesterone acetate [DMPA]) higher risk of acquiring HIV infection compared with non-users. Other studies conducted among sex workers have found similarly elevated risks. Two new studies, one in Uganda, Thailand and Zimbabwe, the other in South Africa, that are pending publication, conducted among family planning service users, found no overall increase in risk of acquiring HIV infection in women who used hormonal contraception compared with women who used non-hormonal contraception or no contraceptive method.

The meeting recommended that there should be no restrictions on the use of oral contraception and DMPA by women at risk of acquiring HIV, consistent with the current WHO Medical Eligibility Criteria for Contraceptive Use guidelines. However, participants suggested that the Guidelines Steering Group reconsider its classification regarding women at high individual risk of HIV infection, for whom some caution on use of these methods may be appropriate. The meeting reiterated the importance of promotion of condom use and called for training for family planning providers in promoting use of dual protection against STIs/HIV and unwanted pregnancy. (1)

(1.) Hormonal contraception and HIV: science and policy. Statement (final), September 2005.
COPYRIGHT 2005 Reproductive Health Matters
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:ROUND UP: HIV/AIDS
Publication:Reproductive Health Matters
Geographic Code:1USA
Date:Nov 1, 2005
Words:304
Previous Article:Evidence that male circumcision reduces HIV acquisition may be flawed.
Next Article:Global midwifery training programme on HIV/AIDS launched.
Topics:


Related Articles
Contradictory evidence on whether or not hormonal contraceptives increase the risk of HIV acquisition in women.
Hormonal contraception and risk of HIV acquisition: Uganda and Zimbabwe.
Hormonal contraception is used by over 100 million women worldwide, and understanding whether its use changes a woman's risk for contracting HIV is a...
Hormonal contraception and HIV acquisition: study finds no overall association.
Why this study is unique.
Research implications for policy-makers.
Does hormonal contraception increase HIV infectivity?
Does hormonal contraception speed HIV progression?
How does HIV therapy affect hormonal contraception?
Men's circumcision status not associated with women's HIV risk: Uganda and Zimbabwe.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters